Helix Medical, LLC, a global manufacturer for the medical device, healthcare, pharmaceutical, biotech, and IVD industries, offers scientific injection molding (SIM) methodology for Liquid Silicone Rubber (LSR) molding at its medical device manufacturing facilities in Massachusetts and California. Scientific injection molding combines product design, tool design, material selection, and process development from the polymer point of view which allows control of the critical process parameters to ensure that parts are optimally produced with zero defects. This methodology has been employed for some time in thermoplastic injection molding but is relatively new to LSR molding. By applying the SIM process to LSR products Helix is able to develop processes where potential defects are identified upfront, before the validation stage, therefore saving clients time and money.
The benefits of SIM include higher yields, lower material consumption, and increased process robustness driven by reliable documentation and data collection. The application of these principles delivers better flow control, fewer visual defects, and increases the part integrity thus delivering a lower cost which is passed on to Helix customers.
“Scientific injection molding allows us to produce consistent product quality through process repeatability from machine to machine, part to part, and set-up to set-up,” said Edward Callahan, vice president/general manager, Helix Medical–Gloucester Operations. “This methodology has allowed us to provide the documented standardized processes and the quality assurance required to support our customers’ regulatory requirements. We deliver superior value for our customers and partners by investing the time upfront during the development stage.”
The benefits of SIM include higher yields, lower material consumption, and increased process robustness driven by reliable documentation and data collection. The application of these principles delivers better flow control, fewer visual defects, and increases the part integrity thus delivering a lower cost which is passed on to Helix customers.
“Scientific injection molding allows us to produce consistent product quality through process repeatability from machine to machine, part to part, and set-up to set-up,” said Edward Callahan, vice president/general manager, Helix Medical–Gloucester Operations. “This methodology has allowed us to provide the documented standardized processes and the quality assurance required to support our customers’ regulatory requirements. We deliver superior value for our customers and partners by investing the time upfront during the development stage.”